Keyword: Isis Pharmaceuticals

News

J&J Buys License Option for Isis Pharma Bowel Drug

07.01.2015 - US over-the-counter drugmaker Johnson & Johnson will pay Isis Pharmaceuticals up to $835 million for the option to license three drugs targeting autoimmune diseases in the bowel...

News

Biogen Bets More On Isis Technology For Neurological Drugs

10.09.2013 - Biogen Idec has agreed to pay another $100 million upfront to Isis Pharmaceuticals as part of a broad collaboration to develop new medicines for neurological disorders, the...